首页>
外国专利>
DRY EYE THERAPEUTIC AGENT COMPRISING NANDROLONE OR ESTER THEREOF OR METHENOLONE OR ESTER THEREOF AS AN ACTIVE INGREDIENT
DRY EYE THERAPEUTIC AGENT COMPRISING NANDROLONE OR ESTER THEREOF OR METHENOLONE OR ESTER THEREOF AS AN ACTIVE INGREDIENT
展开▼
机译:包含NANDROLONE或酯类或间苯二酚或酯类作为活性成分的干眼剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention addresses the problem of providing a novel dry eye therapeutic agent which has an exceptional therapeutic effect on dry eye and with which it is possible to actualize a drug effect over an extended period of time in the lacrimal gland tissue after administration of the drug, from the standpoint of the administration burden imposed on the patient. This dry eye therapeutic agent, containing nandrolone or an ester thereof or methenolone or an ester thereof, exhibits a therapeutic effect on dry eye by increasing the amount of tear lipocalin (TL) in the tears. Administering this dry eye therapeutic agent containing nandrolone or an ester thereof or methenolone or an ester thereof to the eyelid skin makes it possible to actualize a drug effect over an extended period of time in the lacrimal gland tissue.
展开▼